983 followers
Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics. - PubMed - NCBI https://t.co/ftOCOUcLFL
Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics. - PubMed - NCBI https://t.co/ftOCOUcLFL
Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics. https://t.co/L29XFJ980j #leukemia https://t.co/YxNGe1oozs